Stock comparison

LLYvsXOM

Eli Lilly and Co vs Exxon Mobil Corp. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

LLY

Eli Lilly and Co

$927.03

-6.70%

Pharmaceuticals$884.0BNYSE

XOM

Exxon Mobil Corp

$146.44

+22.50%

Energy$650.5BNYSE

60-day price, rebased to 100

LLY -12.77% · XOM +8.60%

Round-by-round

LLY 3·XOM 3

EdgeXOM

Valuation upside

-92.70% vs -13.40% to DCF fair value

EdgeLLY

Balance-sheet strength

Altman Z 15.74 vs 4.88

EdgeLLY

Fundamental quality

Piotroski 6.00 vs 3.00 (of 9)

EdgeXOM

Growth + margins

Rule-of-40 -9.10 vs -3.10

EdgeXOM

60-day momentum

-12.77% vs +8.60% price return

EdgeLLY

Market-cap liquidity

$884.0B vs $650.5B

Verdict

Across 6 categories, the two names are evenly matched — 3 wins each. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy on LLY or XOM

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.